Skip to main content

BARCLAYS PLC

Position in PCVX — Vaxcyte, Inc.

CIK 312069 LONDON, X0

Position in PCVX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,270,149
+$411,328 QoQ
Shares Held
39,053
+22.1% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#129
of 329 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PCVX Over Time

Shares Held

Position Value (USD)

Derivatives in PCVX

reported options exposure · as of Sep 30, 2024
CallValue
$479,934
CallShares
4,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names. PCVX ranks #69 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PCVX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,270,149 39,053
2026-03-31 $1,858,821 31,988
2025-12-31 $13,666,436 296,195
2025-09-30 $14,188,781 393,914
2025-06-30 $14,252,675 438,409
2025-03-31 $8,538,366 226,122
2024-12-31 $20,864,886 254,885
2024-09-30 $23,968,474 209,753
2024-09-30 $479,934 4,200
2024-06-30 $3,775,500 50,000
2024-06-30 $9,661,655 127,952
2024-03-31 $8,829,204 129,252
2024-03-31 $3,415,500 50,000
2024-03-31 $3,415,500 50,000
2023-12-31 $12,666,634 201,698
2023-09-30 $8,687,603 170,412
2023-06-30 $5,069,309 101,508
2023-03-31 $3,455,843 92,205
2022-12-31 $5,459,203 113,852
2022-09-30 $1,439,976 59,999
2022-06-30 $57,576 2,646
2022-03-31 $1,202,670 49,800